MTIM
NVAX icon

Marathon Trading Investment Management’s Novavax NVAX Stock Holding History

Marathon Trading Investment Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-32,400
Closed -$225K – 301
2023
Q1 		$225K Buy
32,400
+18,400
+131% +$169K 0.02% 172
2022
Q4 		$144K Buy
+14,000
New +$247K 0.02% 196

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Marathon Trading Investment Management's NVAX Position: Q2 2023 in Review

Marathon Trading Investment Management sold out of Novavax (NVAX) in Q2 2023, closing a stake of 32,400 shares — an estimated $225K sold.

Marathon Trading Investment Management first reported a position in NVAX in Q4 2022 and held it in 2 quarters. The position peaked at $225K in Q1 2023. 216 funds tracked by Wall St. Rank hold NVAX as of Q2 2023.

  • Marathon Trading Investment Management reported no remaining Novavax position as of Q2 2023 after selling out during the quarter.
  • Marathon Trading Investment Management sold 32,400 Novavax shares in Q2 2023, an estimated $225K.
  • Marathon Trading Investment Management first reported a position in Novavax in Q4 2022 and held it in 2 quarters.
  • Marathon Trading Investment Management's Novavax position peaked at $225K in Q1 2023.
  • 216 funds tracked by Wall St. Rank held Novavax as of Q2 2023.

Based on Marathon Trading Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.